Carlos Gomez-Escalonilla

Carlos Gomez-Escalonilla

Auto-generated profile, based on publicly available information

Carlos Gomez-Escalonilla

Neurology, Hospital Clinico San Carlos, Madrid, Spain

Research Focus & Metrics

Academic Career Length

29Years (1998-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2002 in Journal Of Clinical Neurophysiology
Verified
Journal Article
Closed access
IGIrene García–Morales
Irene García–Morales
MGM. Teresa García
M. Teresa García
LGLucia Galán–Dávila
Lucia Galán–Dávila
CGCarlos Gómez–Escalonilla
Carlos Gómez–Escalonilla
RSRosana Saiz–Díaz
Rosana Saiz–Díaz
JTJulian A. Tejerina
Julian A. Tejerina
Summary The purpose of this study was to analyze the clinical aspects in 130 patients presenting periodic lateralized epileptiform discharges (PLEDs) in their EEG and to compare these results with those found in the literature. Etiology, neurologic deficit, seizure occurrence, and evolution were studied in each patient by historical review. The recordings were obtained on 8- or 16-channel EEGs with electrode placement according to the International 10-20 System. Recordings containing PLEDs were selected. PLEDs were defined as repetitive periodic, focal, or hemispheric epileptiform discharges (spikes, spike and waves, polyspikes, sharp waves) usually recurring every 1 to 2 seconds. The statistical study was carried out via the χ2 test using the computer program SPSS. The main etiology found in this group of patients was stroke (61 of 130 patients). Other processes found were brain infections, tumors, hematomas, and several other entities grouped together as miscellaneous (anoxic encephalopathy, subarachnoid hemorrhage, craniocerebral trauma, Creutzfeldt–Jacob disease, migraine, multiple sclerosis, and aminophylline intoxication). Half of these patients (65 of 130) developed seizures, mostly partial motor seizures. No significant relation between etiology and seizures was found (χ2 = 2.81, P = 0.4222). Seizures recurred in 14 of 130 patients during a follow-up of 14.5 months. PLEDs were not recorded in any EEG at the time of seizure recurrence. PLEDs constitute a distinctive but uncommon EEG phenomenon of repetitive, periodic, and stereotyped lateralized complexes. In agreement with the literature, PLEDs were associated with an acute process and occurred early during the course of the illness in all patients studied and were usually associated with structural lesions, with stroke being the main etiology. Traditionally, seizures occur with PLEDs but it is also accepted that they can exist in patients who never develop epileptic activity, either clinically or electrically, as demonstrated in 50% of the patients studied. No significant association between seizures and any etiology could be found. It was not demonstrated that the occurrence of seizures may influence the outcome in any way.

1 November 2020 in Stroke
Verified
Journal Article
Closed access
PDF file
CPCarlos Pérez-García
Carlos Pérez-García
MMManuel Moreu
Manuel Moreu
SRSantiago Rosati
Santiago Rosati
PSPatricia Simal
Patricia Simal
JEJose Antonio Egido
Jose Antonio Egido
JAJuan Arrazola
Juan Arrazola
Background and Purpose: Mechanical thrombectomy techniques for intracranial medium vessel occlusions (MeVOs) have evolved in recent years, although the optimal approach is still unclear. The aim of this study was to investigate the effectiveness and safety of mechanical thrombectomy in MeVOs using mini (0.017 inches microcatheter compatible) stent retrievers combined with low-profile (0.035 inches distal inner diameter) distal aspiration catheters through the blind exchange/mini-pinning (BEMP) technique compared with mini stent retrievers alone. Methods: Retrospective review of a prospectively maintained database of patients treated with the BEMP technique or mini stent retriever alone for intracranial MeVOs from 2017 to 2020 in a comprehensive stroke center. Both groups were compared about baseline characteristics, occlusion site, clinical presentation, clot cause, procedural outcomes (MeVO first-pass and final expanded Thrombolysis in Cerebral Ischemia score, the mini stent retriever used, number of passes with the front-line approach, and need of rescue therapy), safety outcomes (emboli to unwanted territories and hemorrhagic complications), and clinical outcomes at 90 days. Multivariable logistic regression analysis was performed with potential predictors of vessel recanalization to find independent variables associated with MeVO first-pass expanded Thrombolysis in Cerebral Ischemia 2c/3 recanalization. Results: We reviewed 102 patients/106 MeVOs treated with the BEMP technique (n=56) or mini stent retriever (n=50). There was a higher rate of MeVO first-pass expanded Thrombolysis in Cerebral Ischemia 2c/3 recanalization (57% versus 34%, P =0.017), lower need of rescue therapy (7.1% versus 22%, P =0.028), and lower rate of emboli to new territory (1.8% versus 12%, P =0.035) and symptomatic intracranial hemorrhage (1.9% versus 12.8%, P =0.038) with the BEMP technique. After multivariable analysis, the sole independent factor associated to MeVO first-pass expanded Thrombolysis in Cerebral Ischemia 2c/3 recanalization was the BEMP technique (odds ratio, 2.72 [95% CI, 1.19–6.22]; P =0.018). Conclusions: In the setting of MeVOs, the BEMP technique may lead to higher rates of the first-pass recanalization and a lower incidence of symptomatic intracranial hemorrhage than mini stent retrievers alone.

11 August 2000 in Journal of Neural Transmission
Verified
Journal Article
Closed access
PDF file
JMJ. A. Molina
J. A. Molina
FBF. de Bustos
F. de Bustos
FJF. J. Jiménez-Jiménez
F. J. Jiménez-Jiménez
CGC. Gómez-Escalonilla
C. Gómez-Escalonilla
AGA. García-Redondo
A. García-Redondo
JAJ. Arenas
J. Arenas

16 December 1998 in Journal of Neural Transmission
Verified
Journal Article
Closed access
PDF file
MAM Victorina Aguilar
M Victorina Aguilar
FJF. J. Jiménez-Jiménez
F. J. Jiménez-Jiménez
JMJ. A. Molina
J. A. Molina
IMI. Meseguer
I. Meseguer
CMC. J. Mateos-Vega
C. J. Mateos-Vega
MMM. C. Martínez-Para
M. C. Martínez-Para

1 October 2002 in European Neurology
Verified
Journal Article
Closed access
PDF file
JMJ.A. Molina
J.A. Molina
JGJ.M. García-Segura
J.M. García-Segura
JBJ. Benito-León
J. Benito-León
CGC. Gómez-Escalonilla
C. Gómez-Escalonilla
TST. del Ser
T. del Ser
JVJ. Viaño
J. Viaño
Proton magnetic resonance spectroscopy (1H-MRS) provides a non-invasive, in vivo insight into the brain metabolism, and has been successfully used in several neurological conditions. Our objective was to characterise the cerebral metabolic changes in dementia with Lewy bodies (DLB) patients using 1H-MRS. Single Voxel 1H-MRS was performed in 12 DLB patients with mild to moderate symptoms and 11 age-matched healthy controls. Volumes of interest (VOI) were selected, including white matter (WM) in the centrum semiovale and grey matter (GM) in the parasagittal parietal cortex. Main metabolic peaks corresponding to N-acetylaspartate (NAA), glutamate/glutamine (Glx), choline-containing compounds (Cho), myo-inositol (Ins), and creatine plus phosphocreatine (Cr) were identified. These areas were measured and referred to that of the water. Metabolic ratios among the different peak areas were also calculated. In comparison with the control group, DLB patients showed significantly lower mean NAA/Cr, Glx1/Cr and Cho/Cr ratios in the WM, while their Ins/Cr and Ins/NAA ratios did not differ from those of the control group. In the GM, no significant differences were found between both groups. Correlations between age at onset, disease duration, Mini-Mental State Examination, the motor section of the Unified Parkinson’s Disease Rating Scale, Hoehn and Yahr staging and metabolic ratios, both for WM and GM, were not significant in DLB patients. Our spectroscopy data show WM involvement, along with GM preservation, in DLB patients with early or intermediate stages. Hence, 1H-MRS may provide adjunctive information in the ante-mortem diagnosis of DLB.

11 December 2002 in Acta Neurologica Scandinavica
Verified
Journal Article
Closed access
PDF file
JMJ. A. Molina
J. A. Molina
FJF. J. Jiménez-Jiménez
F. J. Jiménez-Jiménez
CVC. Vargas
C. Vargas
PGP. Gómez
P. Gómez
FBF. De Bustos
F. De Bustos
JAJ. Arenas
J. Arenas
Objectives – Some previous reports suggested a potential role of insulin in memory and in the pathophysiology of Alzheimer's disease (AD). We assessed the cerebrospinal fluid (CSF) levels of insulin in patients with AD and in age and sex‐matched controls trying to elucidate whether this value could be related with the risk or severity of AD. Patients and methods – We measured the CSF insulin levels in 27 patients with AD and 16 matched controls using a RadioImmunoanalysis method. Results – CSF insulin levels did not differ significantly between AD‐patient and control groups. These values were not correlated with age, age at onset, duration of the disease, and scores of the MiniMental State Examination in the AD group. Conclusion – These results suggest that CSF insulin concentrations are not related with the risk or severity of AD.